What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - Year 2017 Referencia Ann Oncol. 2017 Dec 1;28(12):2913-2914. doi: 10.1093/annonc/mdx632. Tipus publicació Editorail in international publication DOI http://dx.doi.org/10.1093/annonc/mdx632 Revista ANNALS OF ONCOLOGY Títol Complet DPYD genotype-guided fluoropyrimidines dose: is it ready for prime time? Factor d'impacte 11.86 Codi 9357 PMID https://pubmed.ncbi.nlm.nih.gov/29045550 Nom Autors Paez, D, Salazar, R, Tabernero, J et al. DOI número 10.1093/annonc/mdx632 Year 2017 Referencia Ann Oncol. 2017 Nov 1;28(11):2648-2657. doi: 10.1093/annonc/mdx401. Tipus publicació Review in international publication DOI http://dx.doi.org/10.1093/annonc/mdx401 Revista ANNALS OF ONCOLOGY Títol Complet BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives. Factor d'impacte 11.86 Codi 9358 PMID https://pubmed.ncbi.nlm.nih.gov/29045527 Nom Autors Sanz-Garcia, E, Argiles, G, Elez, E, Tabernero, J et al. DOI número 10.1093/annonc/mdx401 Year 2017 Referencia Ann Oncol. 2017 Dec 1;28(12):2994-2999. doi: 10.1093/annonc/mdx536. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1093/annonc/mdx536 Revista ANNALS OF ONCOLOGY Títol Complet Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS). Factor d'impacte 11.86 Codi 9359 PMID https://pubmed.ncbi.nlm.nih.gov/29045512 Nom Autors Carranza, A, Sancho, P, Martinez-Trufero, J, Diaz-Beveridge, R, Cruz, J, Encinas, V, Taron, M, Moura, D S, Luna, P, Hindi, N et al. DOI número 10.1093/annonc/mdx536 Year 2017 Referencia Cancer Chemother Pharmacol. 2017 Dec;80(6):1113-1131. doi: 10.1007/s00280-017-3436-0. Epub 2017 Oct 16. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1007/s00280-017-3436-0 Revista CANCER CHEMOTHERAPY AND PHARMACOLOGY Títol Complet Malignant bone tumors (other than Ewing's): clinical practice guidelines for diagnosis, treatment and follow-up by Spanish Group for Research on Sarcomas (GEIS). Factor d'impacte 2.74 Codi 9360 PMID https://pubmed.ncbi.nlm.nih.gov/29038849 Nom Autors Redondo, Andres, Bague, Silvia, Bernabeu, Daniel, Ortiz-Cruz, Eduardo, Valverde, Claudia, Alvarez, Rosa, Martinez-Trufero, Javier, Lopez-Martin, Jose A, Correa, Raquel, Cruz, Josefina et al. DOI número 10.1007/s00280-017-3436-0 Year 2017 Referencia J Clin Oncol. 2017 Dec 10;35(35):3924-3933. doi: 10.1200/JCO.2017.74.3062. Epub 2017 Oct 12. Tipus publicació Clinical guide DOI http://dx.doi.org/10.1200/JCO.2017.74.3062 Revista JOURNAL OF CLINICAL ONCOLOGY Títol Complet Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057). Factor d'impacte 24.01 Codi 9361 PMID https://pubmed.ncbi.nlm.nih.gov/29023213 Nom Autors Healey, Diane, Brahmer, Julie, Eberhardt, Wilfried E E, Blackwood-Chirchir, Anne, Li, Ang, Geese, William J, Hellmann, Matthew D, Horn, Leora, Spigel, David R, Vokes, Everett E et al. DOI número 10.1200/JCO.2017.74.3062 Year 2017 Referencia Bone Marrow Transplant. 2017 Dec;52(12):1629-1636. doi: 10.1038/bmt.2017.197. Epub 2017 Oct 9. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1038/bmt.2017.197 Revista BONE MARROW TRANSPLANTATION Títol Complet Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis. Factor d'impacte 3.87 Autors Pere Barba Suñol Codi 9362 PMID https://pubmed.ncbi.nlm.nih.gov/28991247 Nom Autors Perales, M-A, Cho, C, Hsu, M, Barba, P, Maloy, M A, Avecilla, S T, Barker, J N, Castro-Malaspina, H, Giralt, S A, Jakubowski, A A et al. DOI número 10.1038/bmt.2017.197 Year 2017 Referencia Ann Oncol. 2017 Oct 1;28(10):2451-2457. doi: 10.1093/annonc/mdx396. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1093/annonc/mdx396 Revista ANNALS OF ONCOLOGY Títol Complet Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC). Factor d'impacte 11.86 Codi 9363 PMID https://pubmed.ncbi.nlm.nih.gov/28961841 Nom Autors Matito, J, Mereu, E, Navarro, A, Cedres, S, Pardo, N, Martinez de Castro, A, Remon, J, Miquel, J M, Guillaumet-Adkins, A, Nadal, E et al. DOI número 10.1093/annonc/mdx396 Year 2017 Referencia Ann Oncol. 2017 Oct 1;28(10):2526-2532. doi: 10.1093/annonc/mdx344. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1093/annonc/mdx344 Revista ANNALS OF ONCOLOGY Títol Complet Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer. Factor d'impacte 11.86 Codi 9364 PMID https://pubmed.ncbi.nlm.nih.gov/28961833 Nom Autors Del Campo, J M, Mailliez, A, Haddad, R I, Vermorken, J B, Tahara, M, Guigay, J, Geoffrois, L, Merlano, M C, Dupuis, N, Kramer, N et al. DOI número 10.1093/annonc/mdx344 Year 2017 Referencia Ann Oncol. 2017 Oct 1;28(10):2625-2626. doi: 10.1093/annonc/mdx329. Tipus publicació Letter or abstract DOI http://dx.doi.org/10.1093/annonc/mdx329 Revista ANNALS OF ONCOLOGY Títol Complet Reply to the letter to the editor 'Can we trust burnout research?' by Bianchi et al. Factor d'impacte 11.86 Codi 9365 PMID https://pubmed.ncbi.nlm.nih.gov/28961831 Nom Autors Banerjee, S, Preusser, M, Tabernero, J, Strijbos, M et al. DOI número 10.1093/annonc/mdx329 Year 2017 Referencia Ann Oncol. 2017 Oct 1;28(10):2489-2495. doi: 10.1093/annonc/mdx333. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1093/annonc/mdx333 Revista ANNALS OF ONCOLOGY Títol Complet Observation as the initial management strategy in patients with mantle cell lymphoma. Factor d'impacte 11.86 Codi 9366 PMID https://pubmed.ncbi.nlm.nih.gov/28961827 Nom Autors Abrisqueta, P, Scott, D W, Slack, G W, Steidl, C, Mottok, A, Gascoyne, R D, Connors, J M, Sehn, L H, Savage, K J, Gerrie, A S et al. DOI número 10.1093/annonc/mdx333 Year 2017 Referencia J Nerv Ment Dis. 2017 Oct;205(10):818-820. doi: 10.1097/NMD.0000000000000732. Tipus publicació Letter or abstract DOI http://dx.doi.org/10.1097/NMD.0000000000000732 Revista JOURNAL OF NERVOUS AND MENTAL DISEASE Títol Complet Commentary on "Future Directions in Vitamin D Research in Psychiatry". Factor d'impacte 1.86 Codi 9367 PMID https://pubmed.ncbi.nlm.nih.gov/28961600 Nom Autors Salavert, Jose et al. DOI número 10.1097/NMD.0000000000000732 Year 2017 Referencia Ann Oncol. 2017 Dec 1;28(12):2932-2942. doi: 10.1093/annonc/mdx514. Tipus publicació Review in international publication DOI http://dx.doi.org/10.1093/annonc/mdx514 Revista ANNALS OF ONCOLOGY Títol Complet Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab. Factor d'impacte 11.86 Codi 9368 PMID https://pubmed.ncbi.nlm.nih.gov/28950290 Nom Autors Chau, I, Sashegyi, A, Binder, P, Arnold, D, Fuchs, C S, Tabernero, J, Ohtsu, A, Zhu, A X, Mackey, J R, Paz-Ares, L et al. DOI número 10.1093/annonc/mdx514 Year 2017 Referencia Sci Rep. 2017 Sep 25;7(1):12262. doi: 10.1038/s41598-017-12135-7. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1038/s41598-017-12135-7 Revista Scientific Reports Títol Complet Microenvironment regulates the expression of miR-21 and tumor suppressor genes PTEN, PIAS3 and PDCD4 through ZAP-70 in chronic lymphocytic leukemia. Factor d'impacte 4.26 Autors Francesc Bosch Albareda Marta Crespo Maull Codi 9369 PMID https://pubmed.ncbi.nlm.nih.gov/28947822 Nom Autors Carpio, Cecilia, Abrisqueta, Pau, Jimenez, Isabel, Purroy, Noelia, Calpe, Eva, Palacio, Carles, Bosch, Francesc, Crespo, Marta, Carabia, Julia et al. DOI número 10.1038/s41598-017-12135-7 Year 2017 Referencia Ann Oncol. 2017 Dec 1;28(12):2943-2949. doi: 10.1093/annonc/mdx501. Tipus publicació Review in international publication DOI http://dx.doi.org/10.1093/annonc/mdx501 Revista ANNALS OF ONCOLOGY Títol Complet Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: an expert taskforce review. Factor d'impacte 11.86 Codi 9370 PMID https://pubmed.ncbi.nlm.nih.gov/28945877 Nom Autors Garcia-Foncillas, J, Alba, E, Aranda, E, Diaz-Rubio, E, Lopez-Lopez, R, Tabernero, J, Vivancos, A et al. DOI número 10.1093/annonc/mdx501 Year 2017 Referencia Ann Oncol. 2017 Oct 1;28(10):2340-2366. doi: 10.1093/annonc/mdx310. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1093/annonc/mdx310 Revista ANNALS OF ONCOLOGY Títol Complet ESMO-Magnitude of Clinical Benefit Scale version 1.1. Factor d'impacte 11.86 Codi 9371 PMID https://pubmed.ncbi.nlm.nih.gov/28945867 Nom Autors Tabernero, J, Cherny, N I, Dafni, U, Bogaerts, J, Latino, N J, Pentheroudakis, G, Douillard, J-Y, de Vries, E G E, Piccart, M J, Zielinski, C et al. DOI número 10.1093/annonc/mdx310 Year 2017 Referencia Br J Cancer. 2017 Nov 7;117(10):1478-1485. doi: 10.1038/bjc.2017.320. Epub 2017 Sep 21. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1038/bjc.2017.320 Revista BRITISH JOURNAL OF CANCER Títol Complet Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer. Factor d'impacte 6.18 Codi 9372 PMID https://pubmed.ncbi.nlm.nih.gov/28934761 Nom Autors Sclafani, Francesco, Brown, Gina, Cunningham, David, Wotherspoon, Andrew, Mendes, Larissa Sena Teixeira, Balyasnikova, Svetlana, Evans, Jessica, Peckitt, Clare, Begum, Ruwaida, Tait, Diana et al. DOI número 10.1038/bjc.2017.320 Year 2017 Referencia Curr Oncol Rep. 2017 Sep 18;19(11):72. doi: 10.1007/s11912-017-0633-2. Tipus publicació Review in international publication DOI http://dx.doi.org/10.1007/s11912-017-0633-2 Revista Current Oncology Reports Títol Complet Optimizing Somatostatin Analog Use in Well or Moderately Differentiated Gastroenteropancreatic Neuroendocrine Tumors. Factor d'impacte 2.61 Codi 9373 PMID https://pubmed.ncbi.nlm.nih.gov/28920153 Nom Autors Garcia-Carbonero, Rocio, Teule, Alex, Capdevila, Jaume, Carmona-Bayonas, Alberto, Jimenez-Fonseca, Paula, Custodio, Ana, Grande, Enrique, Lopez, Carlos et al. DOI número 10.1007/s11912-017-0633-2 Year 2017 Referencia Lancet. 2017 Oct 28;390(10106):1949-1961. doi: 10.1016/S0140-6736(17)32440-6. Epub 2017 Sep 12. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/S0140-6736(17)32440-6 Revista LANCET Títol Complet Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial. Factor d'impacte 47.83 Codi 9374 PMID https://pubmed.ncbi.nlm.nih.gov/28916367 Nom Autors Bologna, A, Coleman, Robert L, Oza, Amit M, Lorusso, Domenica, Aghajanian, Carol, Oaknin, Ana, Dean, Andrew, Colombo, Nicoletta, Weberpals, Johanne I, Clamp, Andrew et al. DOI número 10.1016/S0140-6736(17)32440-6 Year 2017 Referencia Lancet Haematol. 2017 Oct;4(10):e475-e486. doi: 10.1016/S2352-3026(17)30171-0. Epub 2017 Sep 12. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/S2352-3026(17)30171-0 Revista Lancet Haematology Títol Complet Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): final results from a randomised, double-blind, phase 3 study. Factor d'impacte 7.12 Autors Francesc Bosch Albareda Codi 9375 PMID https://pubmed.ncbi.nlm.nih.gov/28916311 Nom Autors Fink, Anna Maria, Bahlo, Jasmin, Robrecht, Sandra, Al-Sawaf, Othman, Aldaoud, Ali, Hebart, Holger, Jentsch-Ullrich, Kathleen, Dorfel, Steffen, Fischer, Kirsten, Wendtner, Clemens-Martin et al. DOI número 10.1016/S2352-3026(17)30171-0 Year 2017 Referencia Ann Oncol. 2017 Sep 1;28(9):2142-2148. doi: 10.1093/annonc/mdx275. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1093/annonc/mdx275 Revista ANNALS OF ONCOLOGY Títol Complet A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer. Factor d'impacte 11.86 Codi 9376 PMID https://pubmed.ncbi.nlm.nih.gov/28911091 Nom Autors Esko, V, Abdalla, K, Verma, U, Benedetti, F, Aoyama, T, Mizuguchi, H, Makris, L, Rosati, G, Elme, A, Feliu, J et al. DOI número 10.1093/annonc/mdx275 Pagination First page « Previous page ‹ … Page 735 Page 736 Current page 737 Page 738 Page 739 … Next page › Last page »
Year 2017 Referencia Ann Oncol. 2017 Dec 1;28(12):2913-2914. doi: 10.1093/annonc/mdx632. Tipus publicació Editorail in international publication DOI http://dx.doi.org/10.1093/annonc/mdx632 Revista ANNALS OF ONCOLOGY Títol Complet DPYD genotype-guided fluoropyrimidines dose: is it ready for prime time? Factor d'impacte 11.86 Codi 9357 PMID https://pubmed.ncbi.nlm.nih.gov/29045550 Nom Autors Paez, D, Salazar, R, Tabernero, J et al. DOI número 10.1093/annonc/mdx632
Year 2017 Referencia Ann Oncol. 2017 Nov 1;28(11):2648-2657. doi: 10.1093/annonc/mdx401. Tipus publicació Review in international publication DOI http://dx.doi.org/10.1093/annonc/mdx401 Revista ANNALS OF ONCOLOGY Títol Complet BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives. Factor d'impacte 11.86 Codi 9358 PMID https://pubmed.ncbi.nlm.nih.gov/29045527 Nom Autors Sanz-Garcia, E, Argiles, G, Elez, E, Tabernero, J et al. DOI número 10.1093/annonc/mdx401
Year 2017 Referencia Ann Oncol. 2017 Dec 1;28(12):2994-2999. doi: 10.1093/annonc/mdx536. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1093/annonc/mdx536 Revista ANNALS OF ONCOLOGY Títol Complet Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS). Factor d'impacte 11.86 Codi 9359 PMID https://pubmed.ncbi.nlm.nih.gov/29045512 Nom Autors Carranza, A, Sancho, P, Martinez-Trufero, J, Diaz-Beveridge, R, Cruz, J, Encinas, V, Taron, M, Moura, D S, Luna, P, Hindi, N et al. DOI número 10.1093/annonc/mdx536
Year 2017 Referencia Cancer Chemother Pharmacol. 2017 Dec;80(6):1113-1131. doi: 10.1007/s00280-017-3436-0. Epub 2017 Oct 16. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1007/s00280-017-3436-0 Revista CANCER CHEMOTHERAPY AND PHARMACOLOGY Títol Complet Malignant bone tumors (other than Ewing's): clinical practice guidelines for diagnosis, treatment and follow-up by Spanish Group for Research on Sarcomas (GEIS). Factor d'impacte 2.74 Codi 9360 PMID https://pubmed.ncbi.nlm.nih.gov/29038849 Nom Autors Redondo, Andres, Bague, Silvia, Bernabeu, Daniel, Ortiz-Cruz, Eduardo, Valverde, Claudia, Alvarez, Rosa, Martinez-Trufero, Javier, Lopez-Martin, Jose A, Correa, Raquel, Cruz, Josefina et al. DOI número 10.1007/s00280-017-3436-0
Year 2017 Referencia J Clin Oncol. 2017 Dec 10;35(35):3924-3933. doi: 10.1200/JCO.2017.74.3062. Epub 2017 Oct 12. Tipus publicació Clinical guide DOI http://dx.doi.org/10.1200/JCO.2017.74.3062 Revista JOURNAL OF CLINICAL ONCOLOGY Títol Complet Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057). Factor d'impacte 24.01 Codi 9361 PMID https://pubmed.ncbi.nlm.nih.gov/29023213 Nom Autors Healey, Diane, Brahmer, Julie, Eberhardt, Wilfried E E, Blackwood-Chirchir, Anne, Li, Ang, Geese, William J, Hellmann, Matthew D, Horn, Leora, Spigel, David R, Vokes, Everett E et al. DOI número 10.1200/JCO.2017.74.3062
Year 2017 Referencia Bone Marrow Transplant. 2017 Dec;52(12):1629-1636. doi: 10.1038/bmt.2017.197. Epub 2017 Oct 9. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1038/bmt.2017.197 Revista BONE MARROW TRANSPLANTATION Títol Complet Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis. Factor d'impacte 3.87 Autors Pere Barba Suñol Codi 9362 PMID https://pubmed.ncbi.nlm.nih.gov/28991247 Nom Autors Perales, M-A, Cho, C, Hsu, M, Barba, P, Maloy, M A, Avecilla, S T, Barker, J N, Castro-Malaspina, H, Giralt, S A, Jakubowski, A A et al. DOI número 10.1038/bmt.2017.197
Year 2017 Referencia Ann Oncol. 2017 Oct 1;28(10):2451-2457. doi: 10.1093/annonc/mdx396. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1093/annonc/mdx396 Revista ANNALS OF ONCOLOGY Títol Complet Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC). Factor d'impacte 11.86 Codi 9363 PMID https://pubmed.ncbi.nlm.nih.gov/28961841 Nom Autors Matito, J, Mereu, E, Navarro, A, Cedres, S, Pardo, N, Martinez de Castro, A, Remon, J, Miquel, J M, Guillaumet-Adkins, A, Nadal, E et al. DOI número 10.1093/annonc/mdx396
Year 2017 Referencia Ann Oncol. 2017 Oct 1;28(10):2526-2532. doi: 10.1093/annonc/mdx344. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1093/annonc/mdx344 Revista ANNALS OF ONCOLOGY Títol Complet Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer. Factor d'impacte 11.86 Codi 9364 PMID https://pubmed.ncbi.nlm.nih.gov/28961833 Nom Autors Del Campo, J M, Mailliez, A, Haddad, R I, Vermorken, J B, Tahara, M, Guigay, J, Geoffrois, L, Merlano, M C, Dupuis, N, Kramer, N et al. DOI número 10.1093/annonc/mdx344
Year 2017 Referencia Ann Oncol. 2017 Oct 1;28(10):2625-2626. doi: 10.1093/annonc/mdx329. Tipus publicació Letter or abstract DOI http://dx.doi.org/10.1093/annonc/mdx329 Revista ANNALS OF ONCOLOGY Títol Complet Reply to the letter to the editor 'Can we trust burnout research?' by Bianchi et al. Factor d'impacte 11.86 Codi 9365 PMID https://pubmed.ncbi.nlm.nih.gov/28961831 Nom Autors Banerjee, S, Preusser, M, Tabernero, J, Strijbos, M et al. DOI número 10.1093/annonc/mdx329
Year 2017 Referencia Ann Oncol. 2017 Oct 1;28(10):2489-2495. doi: 10.1093/annonc/mdx333. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1093/annonc/mdx333 Revista ANNALS OF ONCOLOGY Títol Complet Observation as the initial management strategy in patients with mantle cell lymphoma. Factor d'impacte 11.86 Codi 9366 PMID https://pubmed.ncbi.nlm.nih.gov/28961827 Nom Autors Abrisqueta, P, Scott, D W, Slack, G W, Steidl, C, Mottok, A, Gascoyne, R D, Connors, J M, Sehn, L H, Savage, K J, Gerrie, A S et al. DOI número 10.1093/annonc/mdx333
Year 2017 Referencia J Nerv Ment Dis. 2017 Oct;205(10):818-820. doi: 10.1097/NMD.0000000000000732. Tipus publicació Letter or abstract DOI http://dx.doi.org/10.1097/NMD.0000000000000732 Revista JOURNAL OF NERVOUS AND MENTAL DISEASE Títol Complet Commentary on "Future Directions in Vitamin D Research in Psychiatry". Factor d'impacte 1.86 Codi 9367 PMID https://pubmed.ncbi.nlm.nih.gov/28961600 Nom Autors Salavert, Jose et al. DOI número 10.1097/NMD.0000000000000732
Year 2017 Referencia Ann Oncol. 2017 Dec 1;28(12):2932-2942. doi: 10.1093/annonc/mdx514. Tipus publicació Review in international publication DOI http://dx.doi.org/10.1093/annonc/mdx514 Revista ANNALS OF ONCOLOGY Títol Complet Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab. Factor d'impacte 11.86 Codi 9368 PMID https://pubmed.ncbi.nlm.nih.gov/28950290 Nom Autors Chau, I, Sashegyi, A, Binder, P, Arnold, D, Fuchs, C S, Tabernero, J, Ohtsu, A, Zhu, A X, Mackey, J R, Paz-Ares, L et al. DOI número 10.1093/annonc/mdx514
Year 2017 Referencia Sci Rep. 2017 Sep 25;7(1):12262. doi: 10.1038/s41598-017-12135-7. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1038/s41598-017-12135-7 Revista Scientific Reports Títol Complet Microenvironment regulates the expression of miR-21 and tumor suppressor genes PTEN, PIAS3 and PDCD4 through ZAP-70 in chronic lymphocytic leukemia. Factor d'impacte 4.26 Autors Francesc Bosch Albareda Marta Crespo Maull Codi 9369 PMID https://pubmed.ncbi.nlm.nih.gov/28947822 Nom Autors Carpio, Cecilia, Abrisqueta, Pau, Jimenez, Isabel, Purroy, Noelia, Calpe, Eva, Palacio, Carles, Bosch, Francesc, Crespo, Marta, Carabia, Julia et al. DOI número 10.1038/s41598-017-12135-7
Year 2017 Referencia Ann Oncol. 2017 Dec 1;28(12):2943-2949. doi: 10.1093/annonc/mdx501. Tipus publicació Review in international publication DOI http://dx.doi.org/10.1093/annonc/mdx501 Revista ANNALS OF ONCOLOGY Títol Complet Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: an expert taskforce review. Factor d'impacte 11.86 Codi 9370 PMID https://pubmed.ncbi.nlm.nih.gov/28945877 Nom Autors Garcia-Foncillas, J, Alba, E, Aranda, E, Diaz-Rubio, E, Lopez-Lopez, R, Tabernero, J, Vivancos, A et al. DOI número 10.1093/annonc/mdx501
Year 2017 Referencia Ann Oncol. 2017 Oct 1;28(10):2340-2366. doi: 10.1093/annonc/mdx310. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1093/annonc/mdx310 Revista ANNALS OF ONCOLOGY Títol Complet ESMO-Magnitude of Clinical Benefit Scale version 1.1. Factor d'impacte 11.86 Codi 9371 PMID https://pubmed.ncbi.nlm.nih.gov/28945867 Nom Autors Tabernero, J, Cherny, N I, Dafni, U, Bogaerts, J, Latino, N J, Pentheroudakis, G, Douillard, J-Y, de Vries, E G E, Piccart, M J, Zielinski, C et al. DOI número 10.1093/annonc/mdx310
Year 2017 Referencia Br J Cancer. 2017 Nov 7;117(10):1478-1485. doi: 10.1038/bjc.2017.320. Epub 2017 Sep 21. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1038/bjc.2017.320 Revista BRITISH JOURNAL OF CANCER Títol Complet Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer. Factor d'impacte 6.18 Codi 9372 PMID https://pubmed.ncbi.nlm.nih.gov/28934761 Nom Autors Sclafani, Francesco, Brown, Gina, Cunningham, David, Wotherspoon, Andrew, Mendes, Larissa Sena Teixeira, Balyasnikova, Svetlana, Evans, Jessica, Peckitt, Clare, Begum, Ruwaida, Tait, Diana et al. DOI número 10.1038/bjc.2017.320
Year 2017 Referencia Curr Oncol Rep. 2017 Sep 18;19(11):72. doi: 10.1007/s11912-017-0633-2. Tipus publicació Review in international publication DOI http://dx.doi.org/10.1007/s11912-017-0633-2 Revista Current Oncology Reports Títol Complet Optimizing Somatostatin Analog Use in Well or Moderately Differentiated Gastroenteropancreatic Neuroendocrine Tumors. Factor d'impacte 2.61 Codi 9373 PMID https://pubmed.ncbi.nlm.nih.gov/28920153 Nom Autors Garcia-Carbonero, Rocio, Teule, Alex, Capdevila, Jaume, Carmona-Bayonas, Alberto, Jimenez-Fonseca, Paula, Custodio, Ana, Grande, Enrique, Lopez, Carlos et al. DOI número 10.1007/s11912-017-0633-2
Year 2017 Referencia Lancet. 2017 Oct 28;390(10106):1949-1961. doi: 10.1016/S0140-6736(17)32440-6. Epub 2017 Sep 12. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/S0140-6736(17)32440-6 Revista LANCET Títol Complet Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial. Factor d'impacte 47.83 Codi 9374 PMID https://pubmed.ncbi.nlm.nih.gov/28916367 Nom Autors Bologna, A, Coleman, Robert L, Oza, Amit M, Lorusso, Domenica, Aghajanian, Carol, Oaknin, Ana, Dean, Andrew, Colombo, Nicoletta, Weberpals, Johanne I, Clamp, Andrew et al. DOI número 10.1016/S0140-6736(17)32440-6
Year 2017 Referencia Lancet Haematol. 2017 Oct;4(10):e475-e486. doi: 10.1016/S2352-3026(17)30171-0. Epub 2017 Sep 12. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/S2352-3026(17)30171-0 Revista Lancet Haematology Títol Complet Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): final results from a randomised, double-blind, phase 3 study. Factor d'impacte 7.12 Autors Francesc Bosch Albareda Codi 9375 PMID https://pubmed.ncbi.nlm.nih.gov/28916311 Nom Autors Fink, Anna Maria, Bahlo, Jasmin, Robrecht, Sandra, Al-Sawaf, Othman, Aldaoud, Ali, Hebart, Holger, Jentsch-Ullrich, Kathleen, Dorfel, Steffen, Fischer, Kirsten, Wendtner, Clemens-Martin et al. DOI número 10.1016/S2352-3026(17)30171-0
Year 2017 Referencia Ann Oncol. 2017 Sep 1;28(9):2142-2148. doi: 10.1093/annonc/mdx275. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1093/annonc/mdx275 Revista ANNALS OF ONCOLOGY Títol Complet A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer. Factor d'impacte 11.86 Codi 9376 PMID https://pubmed.ncbi.nlm.nih.gov/28911091 Nom Autors Esko, V, Abdalla, K, Verma, U, Benedetti, F, Aoyama, T, Mizuguchi, H, Makris, L, Rosati, G, Elme, A, Feliu, J et al. DOI número 10.1093/annonc/mdx275
